| 000 | 01483 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517160340.0 | ||
| 264 | 0 | _c20190111 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a2045-2322 | ||
| 024 | 7 |
_a10.1038/s41598-017-03304-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCreemers, A | |
| 245 | 0 | 0 |
_aDiscordance in HER2 Status in Gastro-esophageal Adenocarcinomas: A Systematic Review and Meta-analysis. _h[electronic resource] |
| 260 |
_bScientific reports _c06 2017 |
||
| 300 |
_a3135 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aEsophageal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aGene Amplification |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
| 650 | 0 | 4 |
_aStomach Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aTrastuzumab _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aTer Veer, E | |
| 700 | 1 | _ade Waal, L | |
| 700 | 1 | _aLodder, P | |
| 700 | 1 | _aHooijer, G K J | |
| 700 | 1 | _avan Grieken, N C T | |
| 700 | 1 | _aBijlsma, M F | |
| 700 | 1 | _aMeijer, S L | |
| 700 | 1 | _avan Oijen, M G H | |
| 700 | 1 | _avan Laarhoven, H W M | |
| 773 | 0 |
_tScientific reports _gvol. 7 _gno. 1 _gp. 3135 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41598-017-03304-9 _zAvailable from publisher's website |
| 999 |
_c27264150 _d27264150 |
||